Verified email-pattern data for Pulmocide is currently limited. You can still use the company insights and contact sections below.
Pulmocide is a biopharmaceutical company that specializes in tackling difficult-to-treat respiratory diseases. We focus on respiratory fungal infections that can be serious and life-threatening and have significant effects on patients’ quality of life. Our current clinical development focus is on treating patients who have not successfully responded to the standard of care and on the prophylactic treatment of lung transplant patients. Pulmocide’s innovative approach to drug development provides a novel potential therapy that has been specifically designed to treat the most common fungal lung disease, pulmonary aspergillosis. Opelconazole was designed for inhaled delivery to minimize systemic exposure and deliver a high concentration of drug with a long retention time at the site of infection. This approach could improve treatment outcomes in patients with fungal lung disease without increasing systemic side effects and without interactions with other medications.
The Pulmocide team is well experienced in the discovery and development of inhaled therapies for respiratory and infectious disease indications. They have particular expertise in the identification of novel compounds that can be delivered directly to the lungs.
Company Details
- Employees
- 29
- Founded
- -
- Address
- London, Gb
- Industry
- Biotechnology Research
- Website
- https://pulmocide.com/
- Keywords
- Severe respiratory diseases, Inhaled therapeutics, Pulmonary aspergillosis, Pharmaceuticals, Acute and chronic lung infections, Pulmonary.
- HQ
- London
Pulmocide Questions
Pulmocide's website is https://pulmocide.com/
Pulmocide's LinkedIn profile is https://www.linkedin.com/company/pulmocide
Pulmocide has
29 employees.
View email and phone details for 29
employees at Pulmocide.
Pulmocide's industry is
Biotechnology Research
Pulmocide's top competitors are
Bit.bio,
Evox Therapeutics Ltd,
Cell And Gene Therapy Catapult,
Quell Therapeutics,
Cellcentric,
Ellipses Pharma,
Touchlight,
Autolus Therapeutics,
Aviadobio,
Artios.
Pulmocide's categories are Biotechnology Research
Pulmocide's founding year is 2013
Explore related pages
Related company profiles:
Top Pulmocide Employees
-
Anna Thorner, MD, FIDSA
n/a
Boston, Massachusetts, United States, United States -
Paulynn Dorotheo
Executive Director, Head Of Dm
Redwood City, California, United States, United States3relypsa.com, comcast.net, relypsa.com -
Fiona MacLaughlin
n/a
United Kingdom, United Kingdom2hotmail.com, adventls.com -
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.